QR код

Time required to achieve optimum viral load suppression with Ravidasvir/sofosbuvir in chronic hepatitis C patients with or without compensated cirrhosis

Abstract A study indicated that ravidasvir (RDV) has excellent safety and tolerability when used with sofosbuvir (SOF) to treat chronic HCV infection. The aim of this study was to determine the time taken by RDV/SOF to achieve optimum viral load suppression in chronic hepatitis C patients with or wi...

Повний опис

Збережено в:
Автори: Nor Asiah Muhamad, Izzah Athirah Rosli, Nur Hasnah Maamor, Rozainanee Mohd Zain, Fatin Norhasny Leman, Huan-Keat Chan, Muhammad Radzi Abu Hassan, Shahnaz Murad
Формат: Artigo
Мова:Inglês
Опубліковано: Nature Portfolio 2025-04-01
Серія:Scientific Reports
Предмети:
Ravidasvir
Sofosbuvir
Hepatitis
Time-to-event
Virologic response
STORM-C-1
Онлайн доступ:https://doi.org/10.1038/s41598-025-99665-7
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси